SQLite Web: event_store.db

Update row sig_07cafa399fcc in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1680367/0001193125-26-146296.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1680367/0001193125-26-146296.txt","company":"Shattuck Labs, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1680367/0001193125-26-146296.txt","article_chars":4339,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_23f77033f9e2f1b3","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1680367/0001193125-26-146296.txt","content_type":"text/plain","enriched_at":"2026-04-09T16:35:57.900343+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/1680367/0001193125-26-146296.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1680367/0001193125-26-146296.txt","source_event_id":"evt_25341abc10bc","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"4f0afa0e846fbf83","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-02","2026-05-18","2026-05-28","2026-04-09"],"entities":[{"asset_class":"equity","name":"Shattuck Labs, Inc.","relevance":"high","symbol":"STTK","type":"issuer"},{"asset_class":"other","name":"KPMG LLP","relevance":"medium","symbol":"","type":"auditor"},{"asset_class":"other","name":"Taylor Schreiber, M.D., Ph.D.","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"other","name":"Helen M. Boudreau","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"other","name":"Clay Siegall, Ph.D.","relevance":"medium","symbol":"","type":"director_nominee"}],"event_type":"listing","information_gaps":["What specifically changed versus the prior known state is not provided in the supplied text (no prior filing comparison content included).","The filing\u2019s \u201cAmendment No.\u201d field is shown as blank in the cleaned text.","The filing date in the structured context is 2026-04-09, while the source summary states \u201cFiled 20260408\u201d; the discrepancy is not resolved by the provided text.","No financial guidance or financial implications are disclosed in the provided excerpt beyond governance/voting items."],"key_facts":["Form type: DEFA14A (Schedule 14A proxy statement).","Annual Meeting of Stockholders to be held live via the Internet at 11:30 AM Eastern Time on May 28, 2026.","Stockholders of record as of April 2, 2026.","Board recommends voting: \u201cFOR\u201d each director nominee in Proposal 1; \u201cFOR\u201d Proposals 2, 3 and 5; and \u201c1 YEAR\u201d on Proposal 4.","Proposal 1: elect three Class III director nominees (Taylor Schreiber, M.D., Ph.D.; Helen M. Boudreau; Clay Siegall, Ph.D.) to serve until the 2029 Annual Meeting.","Proposal 2: ratify KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.","Proposal 3: non-binding advisory vote to approve compensation of named executive officers.","Proposal 4: advisory vote to determine frequency of future advisory votes on named executive officer compensation.","Proposal 5: approve an amendment and restatement of the Company\u2019s 2020 Equity Incentive Plan.","Proxy materials availability and voting/control-number instructions are provided via www.proxydocs.com/STTK and related ordering instructions."],"numeric_claims":[{"label":"Annual meeting time (ET)","value":"11:30 AM"},{"label":"Annual meeting date","value":"May 28, 2026"},{"label":"Record date","value":"April 2, 2026"},{"label":"Paper request deadline for this year\u2019s meeting","value":"May 18, 2026"},{"label":"Auditor year ending","value":"December 31, 2026"},{"label":"Director term until","value":"2029 Annual Meeting of Stockholders"}],"primary_claim":"Shattuck Labs, Inc. filed Form DEFA14A (Schedule 14A proxy materials) for its annual meeting to be held May 28, 2026, with specified proposals and voting recommendations.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Shattuck Labs, Inc. filed a Schedule 14A proxy statement (DEFA14A) for its 2026 annual meeting of stockholders. The filing includes meeting logistics and outlines five proposals, including director elections, auditor ratification, advisory executive compensation votes, and an equity incentive plan amendment/restatement.","topics":["proxy statement","annual meeting of stockholders","director nominees","independent registered public accounting firm","executive compensation advisory vote","equity incentive plan amendment/restatement","voting recommendations","meeting logistics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Shattuck Labs, Inc. \u00b7 Filed 20260408","ticker":"STTK","tickers":["STTK"],"title":"STTK filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1680367/0001193125-26-146296.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel